Merck (MRK) Current Taxes (2009 - 2026)
Merck (MRK) posted quarterly Current Taxes of $3.9 billion for Q1 2026, down 23.84% year-over-year from $5.2 billion in Q1 2025, and down 16.5% quarter-over-quarter from $4.7 billion in Q4 2025.
Merck (MRK) Current Taxes (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Current Taxes for 18 consecutive years, with $3.9 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Taxes fell 23.84% year-over-year to $3.9 billion; the TTM figure through Mar 2026 stood at $3.9 billion (down 23.84% YoY), while the FY2025 annual figure was $4.7 billion, up 20.75% from the prior year.
- Current Taxes declined to $3.9 billion in Q1 2026 per MRK's latest filing, from $4.7 billion in the prior quarter.
- Across five years, Current Taxes topped out at $5.2 billion in Q1 2025 and bottomed at $1.4 billion in Q2 2022.
- Historically, Current Taxes has averaged $3.0 billion across 5 years, with a median of $2.6 billion in 2023.
- Annual changes were most pronounced in 2024 — Current Taxes jumped 118.58% — and 2026, when it slipped 23.84%.
- Merck's Current Taxes stood at $2.0 billion in 2022, then surged by 33.38% to $2.6 billion in 2023, then soared by 47.75% to $3.9 billion in 2024, then advanced by 20.75% to $4.7 billion in 2025, then dropped by 16.5% to $3.9 billion in 2026.
- Business Quant data shows MRK's Current Taxes at $3.9 billion in Q1 2026, $4.7 billion in Q4 2025, and $4.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.22 Bn |
| Mar 31, 2026 | 3.95 Bn |
| Dec 31, 2025 | 4.73 Bn |
| Sep 30, 2025 | 4.85 Bn |
| Jun 30, 2025 | 4.16 Bn |
| Mar 31, 2025 | 5.18 Bn |
| Dec 31, 2024 | 3.91 Bn |
| Sep 30, 2024 | 4.33 Bn |
| Jun 30, 2024 | 2.78 Bn |
| Mar 31, 2024 | 2.40 Bn |
| Dec 31, 2023 | 2.65 Bn |
| Sep 30, 2023 | 1.98 Bn |
| Jun 30, 2023 | 1.49 Bn |
| Mar 31, 2023 | 1.87 Bn |
| Dec 31, 2022 | 1.99 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.44 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.22 Bn |
| Sep 30, 2021 | 954.00 Mn |